Evaluation of organ-specific glucose metabolism by 18F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance

Annals of Nuclear Medicine

Volumn 25, Issue 10, 2011, Pages 755-761

  Cheng, Chao ^a   Nakamura, Akinobu ^a   Minamimoto, Ryogo ^a,b   Shinoda, Kazuaki ^a   Tateishi, Ukihide ^a   Goto, Atsushi ^b   Kadowaki, Takashi ^c   Terauchi, Yasuo ^a   Inoue, Tomio ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

18F FDG; Glucose metabolism; Insulin receptor substrate 1 (IRS 1); Insulin receptor substrate 1 (IRS 1) knockout mouse; Insulin resistance

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1;

ABDOMINAL WALL MUSCULATURE; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BACK MUSCLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART MUSCLE; INSULIN RESISTANCE; KNOCKOUT MOUSE; LOADING TEST; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; REACTION TIME; STRAIN DIFFERENCE; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; GENE KNOCKOUT TECHNIQUES; INJECTIONS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MICE; MICE, KNOCKOUT; ORGAN SPECIFICITY; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS;

EID: 83855164134     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-011-0522-y     Document Type: Article

References (32)

1. VA Fonseca 2003 Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease Am J Cardiol 92 50J 60J 12957327 10.1016/S0002-9149(03)00616-7
2. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels, Belgium: International Diabetes Federation. 2005. http://www.idf.org/webdata/docs/MetSyndrome-FINAL.pdf. Accessed August 2006.
3. TM Wallace JC Levy DR Matthews 2004 Use and abuse of HOMA modeling Diabetes Care 27 1487 1495 15161807 10.2337/diacare.27.6.1487 (Pubitemid 38680001)
4. RA DeFronzo JD Tobin R Andres 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 E214 E223 382871 1:CAS:528:DyaE1MXlslWhs70%3D
5. K Cusi K Maezono A Osman M Pendergrass ME Patti T Pratipanawatr, et al. 2000 Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle J Clin Invest 105 311 320 10675357 10.1172/JCI7535 1:CAS:528:DC%2BD3cXhtVSltLo%3D (Pubitemid 30094451)
6. A Krook M Bjornholm D Galuska XJ Jiang R Fahlman MG Myers Jr, et al. 2000 Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients Diabetes 49 284 292 10868945 10.2337/diabetes.49.2.284 1:CAS:528:DC%2BD3cXpsl2rsg%3D%3D (Pubitemid 30071007)
7. MF White 2002 IRS proteins and the common path to diabetes Am J Physiol Endocrinol Metab 283 E413 E422 12169433 1:CAS:528:DC%2BD38XntFOnu7s%3D
8. MF White 2003 Insulin signaling in health and disease Science 302 1710 1711 14657487 10.1126/science.1092952 1:CAS:528:DC%2BD3sXpsVWns7s%3D (Pubitemid 37505726)
9. T Yamauchi K Tobe H Tamemoto K Ueki Y Kaburagi R Yamamoto-Honda, et al. 1996 Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice Mol Cell Biol 16 3074 3084 8649419 1:CAS:528:DyaK28XjtFCqtrc%3D
10. CM Taniguchi K Ueki R Kahn 2005 Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism J Clin Invest 115 718 727 15711641 1:CAS:528:DC%2BD2MXit1emt78%3D (Pubitemid 40322247)
11. LM Voipio-Pulkki P Nuutila MJ Knuuti U Ruotsalainen M Haaparanta M Teras, et al. 1993 Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography J Nucl Med 34 2064 2067 8254388 1:STN:280:DyaK2c%2Fns1Sntw%3D%3D (Pubitemid 24002944)
12. T Ohtake I Yokoyama T Watanabe T Momose T Serezawa J Nishikawa, et al. 1995 Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET J Nucl Med 36 456 463 7884509 1:STN:280: DyaK2M7ptVKjsQ%3D%3D
13. T Utriainen T Takala M Luotolahti T Ronnemaa H Laine U Ruotsalainen, et al. 1998 Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM Diabetologia 41 555 559 9628273 10.1007/s001250050946 1:CAS:528:DyaK1cXivValtL4%3D (Pubitemid 28206826)
14. KA Virtanen P Peltoniemi P Marjamaki M Asola L Strindberg R Parkkola, et al. 2001 Human adipose tissue glucose uptake determined using [(18)F]-fluoro-deoxy-glucose ([(18)F]FDG) and PET in combination with microdialysis Diabetologia 44 2171 2179 11793018 10.1007/s001250100026 1:CAS:528:DC%2BD3MXovFWit7c%3D (Pubitemid 34015469)
15. EM Bingham D Hopkins D Smith A Pernet W Hallett L Reed, et al. 2002 The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study Diabetes 51 3384 3390 12453890 10.2337/diabetes.51.12.3384 1:CAS:528:DC%2BD38Xptl2ntbg%3D (Pubitemid 35403440)
16. KH Lee BH Ko JY Paik KH Jung YS Choe Y Choi, et al. 2005 Effects of anesthetic agents and fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice J Nucl Med 46 1531 1536 16157537 1:CAS:528:DC%2BD28XitVGltrw%3D (Pubitemid 46173264)
17. M Vanttinen P Nuutila T Kuulasmaa J Pihlajamaki K Hallsten KA Virtanen, et al. 2005 Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake Diabetes 54 3587 3591 16306381 10.2337/diabetes.54.12.3587 1:CAS:528:DC%2BD2MXht12gsLzM (Pubitemid 43334355)
18. H Tamemoto T Kadowaki K Tobe T Yagi H Sakura T Hayakawa, et al. 1994 Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 Nature 372 182 186 7969452 10.1038/372182a0 1:CAS:528: DyaK2cXmvFehu7k%3D (Pubitemid 24347838)
19. Y Terauchi K Iwamoto H Tamemoto K Komeda C Ishii Y Kanazawa, et al. 1997 Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease J Clin Invest 99 861 866 9062343 10.1172/JCI119250 1:CAS:528:DyaK2sXhs1Kht7c%3D (Pubitemid 27123622)
20. K Hamacher H Coenen G Stocklin 1986 Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution J Nucl Med 27 235 238 3712040 1:CAS:528:DyaL2sXhvV2ntA%3D%3D (Pubitemid 17024868)
21. Y Kido DJ Burks D Withers JC Bruning CR Kahn MF White, et al. 2000 Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2 J Clin Invest 105 199 205 10642598 10.1172/JCI7917 1:CAS:528:DC%2BD3cXltFemtQ%3D%3D (Pubitemid 30054359)
22. E Araki MA Lipes ME Patti JC Bruning B Haag 3rd RS Johnson, et al. 1994 Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene Nature 372 186 190 7526222 10.1038/372186a0 1:CAS:528: DyaK2cXmvFehu7Y%3D (Pubitemid 24347839)
23. I Yokoyama K Yonekura T Ohtake H Kawamura A Matsumoto Y Inoue, et al. 2000 Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with non-insulin-dependent diabetes mellitus J Nucl Cardiol 7 242 248 10888395 10.1016/S1071-3581(00)70013-4 1:STN:280:DC%2BD3cvptlOntg%3D%3D (Pubitemid 30440578)
24. PS MacLean D Zheng JP Jones AL Olson GL Dohm 2002 Exercise-induced transcription of the muscle glucose transporter (GLUT 4) gene Biochem Biophys Res Commun 292 409 414 11906177 10.1006/bbrc.2002.6654 1:CAS:528: DC%2BD38XitFeitr4%3D (Pubitemid 34694279)
25. E Turcotte M Leblanc A Carpentier F Benard 2006 Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-d-glucose Injection following I.V. Insulin in diabetic patients Mol Imaging Biol 8 348 354 17053859 10.1007/s11307-006-0064-1 (Pubitemid 44741372)
26. DE Kelley MA Mintun SC Watkins JA Simoneau F Jadali A Fredrickson, et al. 1996 The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle J Clin Invest 97 2705 2713 8675680 10.1172/JCI118724 1:CAS:528:DyaK28XjvVWksro%3D (Pubitemid 26197085)
27. Z Yi P Langlais EA De Filippis M Luo CR Flynn S Schroeder, et al. 2007 Global assessment of regulation of phosphorylation of insulin receptor substrate-1 by insulin in vivo in human muscle Diabetes 56 1508 1516 17360977 10.2337/db06-1355 1:CAS:528:DC%2BD2sXmtlKiu7g%3D (Pubitemid 46842594)
28. RA DeFronzo E Ferrannini Y Sato P Felig J Wahren 1981 Synergistic interaction between exercise and insulin on peripheral glucose uptake J Clin Invest 68 1468 1474 7033285 10.1172/JCI110399 1:CAS:528:DyaL38XpvVWgtg%3D%3D (Pubitemid 12194401)
29. AD Baron 1994 Hemodynamic actions of insulin Am J Physiol 267 E187 E202 8074198 1:CAS:528:DyaK2cXlslSlsLc%3D
30. A Klip T Ramlal DA Young JO Holloszy 1987 Insulin-induced translocation of glucose transporters in rat hindlimb muscles FEBS Lett 224 224 230 2960560 10.1016/0014-5793(87)80452-0 1:CAS:528:DyaL1cXjt1ektw%3D%3D (Pubitemid 17159998)
31. JM Huitink FC Visser GR van Leeuwen A van Lingen JJ Bax RJ Heine, et al. 1995 Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle, assessed by planar imaging Eur J Nucl Med 22 1141 1148 8542898 10.1007/BF00800596 1:CAS:528:DyaK2MXpvFylsL0%3D
32. P Peltoniemi P Lonnroth H Laine V Oikonen T Tolvanen T Gronroos, et al. 2000 Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans Am J Physiol Endocrinol Metab 279 E1122 E1130 11052968 1:CAS:528:DC%2BD3cXotFaqsLw%3D